IP Library Assignment 023484/0145
Patent Assignment
Reel/Frame 023484/0145

Assignment of Assignor's Interest

Recorded: 2009-11-06 Pages: 11
Assignors
ANDERSON, MARK B.
Executed: 2009-07-14
WILLARDSEN, J. ADAM
Executed: 2009-07-13
WEINER, WARREN S.
Executed: 2009-07-15
YUNGAI, ASHANTAI
Executed: 2009-09-10
HALTER, ROBERT J.
Executed: 2009-07-13
KLIMOVA, YEVGENIYA
Executed: 2009-07-28
SUZUKI, KAZUYUKI
Executed: 2009-07-13
REEDER, MATTHEW
Executed: 2009-11-02
Assignee
MYRIAD PHARMACEUTICALS, INC.
320 WAKARA WAY, SALT LAKE CITY, UTAH, 84108
Covered Property (1)
Compounds and Therapeutical Use Thereof
Patent: 8,309,562 →
Application: 12/500,863 →
Publication: US 2010/0069383
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name Aug 18, 2010
From: MYRIAD PHARMACEUTICALS, INC.
To: MYREXIS, INC.
Reel/Frame 024855/0213 →
Security Agreement Feb 19, 2014
From: IMMUNE PHARMACEUTICALS INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
To: MIDCAP FUNDING III, LLC
Reel/Frame 032277/0353 →
Release of Security Interest Aug 5, 2015
From: MIDCAP FINANCIAL TRUST
To: IMMUNE PHARMACEUTICALS, INC.; MAXIM PHARMACEUTICALS, INC.; CYTOVIA, INC.
Reel/Frame 036255/0778 →